Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
Investigators postulate that the metabolic effects of LSG would be augmented with the use of
liraglutide leading to additional excess weight loss, improved glucose homeostasis, decreased
intrapancreatic and intrahepatic fat than either of them individually. However there are no
studies till date which have evaluated the combined effects of two modalities of weight loss
on the above mentioned parameters. This study plans to compare the effects of liraglutide in
post- LSG obese patients in a placebo controlled design.
Phase:
Phase 3
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research